Related Experiment Video
Updated: Mar 9, 2026

03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
1.1K
Global Prioritizing Disease Candidate lncRNAs via a Multi-level Composite Network.
Qianlan Yao1, Leilei Wu1, Jia Li2,3
1School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200031, China.
Scientific Reports
|January 5, 2017
Summary
Researchers developed LncPriCNet, a novel algorithm to identify long non-coding RNAs (lncRNAs) linked to diseases. This tool prioritizes disease-associated lncRNAs, aiding in understanding human disease mechanisms.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Long non-coding RNAs (lncRNAs) are crucial in biological processes, but their roles in human diseases remain largely unexplored.
- Prioritizing disease-associated lncRNAs is essential for advancing disease research and understanding molecular mechanisms.
Purpose of the Study:
- To develop a novel algorithm, LncPriCNet, for prioritizing candidate long non-coding RNAs (lncRNAs) associated with human diseases.
- To evaluate the performance of LncPriCNet against existing methods and assess its utility in data-scarce scenarios.
Main Methods:
- Developed LncPriCNet, a multi-level composite network algorithm integrating genes, lncRNAs, phenotypes, and their associations.
- Applied LncPriCNet to identify disease-related lncRNAs, including novel candidates for breast cancer.
- Constructed a human disease-lncRNA landscape to analyze network modularity and identify lncRNA hotspots.
Main Results:
- LncPriCNet demonstrated superior performance compared to previous methods, achieving high Area Under the Curve (AUC) values up to 0.93.
- The algorithm effectively identified known and novel disease-related lncRNAs, even with limited prior information.
- Pathway analysis of identified lncRNAs provided insights into their potential functions in breast cancer.
Conclusions:
- LncPriCNet is an effective tool for prioritizing disease-associated lncRNAs, facilitating the discovery of novel disease mechanisms.
- The study contributes to understanding the complex landscape of human diseases at the lncRNA level.
Related Concept Videos
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
Protein Networks
4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K

